Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ABHD17A pseudogene 8 (ABHD17AP8) is classified as an unprocessed pseudogene in humans and does not encode a functional protein. It is located on chromosome 16 and is also known by the alias FAM108A9P. As a pseudogene, ABHD17AP8 does not possess known biological function, disease association, or therapeutic target relevance, and it is not considered a receptor, enzyme, transporter, or other druggable molecular target[1][7][9][10].\n\nKey clarifications:\n- Although ABHD17A (the protein-coding gene) has established roles as a depalmitoylase, ABHD17AP8 is a pseudogene and does not produce a functional protein[3][7][9].\n- No evidence links ABHD17AP8 to drugs, mechanisms of action, biomarkers, or safety concerns.\n- As a pseudogene, it is not considered a therapeutic target by standard definitions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ABHD17A pseudogene 8 (ABHD17AP8).